waiting times

Hospital Particular Alvor


Urgent Care

Hospital Particular Gambelas


Urgent Care

Over 1H30


Madeira Medical Center


Urgent Care


Innovative Immunotherapy in Bladder Cancer

Today, at HPA Gambelas, one of the first patients (nationally) started innovative immunotherapy for advanced bladder cancer, capable of reducing the risk of mortality by 31%.

According to oncologist Dr. André Andraz Cruz ""treatment with immunotherapy in advanced bladder cancer has been a reality since 2017. However, it was only recommended in some patients (in 1st line if PD-L1 positive or 2nd line after chemotherapy failure ). Based on the Javelin-100 study, the European Medicines Agency approved the drug Avelumab (Bavencio®)  on 25th January 2021 for all patients who respond to initial chemotherapy. This recent immunotherapy treatment, considered maintenance, increases overall survival, decreasing the risk of death by 31%. These are very encouraging results in this disease and the Oncology Unit of the Gambelas Unit is pleased to have started its first treatment today, one of the pioneers on a national level.

26th February 2021

Day Care Hospital

26, February 2021